Rocket


Overview
Financials
News + Filings
Key Docs
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Roivant Sciences Ltd. (ROIV) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
10/06/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
10/04/2023 SC 13D/A Roivant Sciences Ltd. reports a 55.3% stake in Immunovant, Inc.
10/04/2023 144 Form 144 - Report of proposed sale of securities:
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 144 Form 144 - Report of proposed sale of securities:
09/29/2023 144 Form 144 - Report of proposed sale of securities:
09/29/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
09/29/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Form of Common Share Purchase and Sale Agreement",
"Opinion of Conyers Dill & Pearman Limited"
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/28/2023 144 Form 144 - Report of proposed sale of securities:
09/27/2023 144 Form 144 - Report of proposed sale of securities:
09/26/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/21/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BASEL, Switzerland and LONDON and NEW YORK, August 17, 2023",
"Notice of Redemption Fair Market Value"
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/14/2023 8-K Quarterly results
Docs: "Roivant Reports Financial Results for the First Quarter Ended June 30, 2023, and Provides Business Update"
08/07/2023 ARS Form ARS - Annual Report to Security Holders:
08/04/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "BASEL, Switzerland and LONDON and NEW YORK and BOSTON, August 2, 2023",
"Notice of Redemption"
08/01/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 144 Form 144 - Report of proposed sale of securities:
07/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
07/31/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy